На информационном ресурсе применяются рекомендательные технологии (информационные технологии предоставления информации на основе сбора, систематизации и анализа сведений, относящихся к предпочтениям пользователей сети "Интернет", находящихся на территории Российской Федерации)

Feedbox

12 подписчиков

FDA Approves World’s First Device That Could Save Thousands of Preemies From Common Heart Condition

Source: Good News Network

The U.S. Food and Drug Administration (FDA) has just approved a device from one of the most common life-threatening conditions for prematurely born babies.

The Amplatzer Piccolo Occluder is the world’s first medical device that can be implanted in the tiniest babies (weighing as little as two pounds) using a minimally invasive procedure to treat patent ductus arteriosus, or PDA.

The Amplatzer Piccolo, a device even smaller than a small pea, now offers hope to premature infants and newborns who need corrective treatment, and who may be non-responsive to medical management and high risk to undergo corrective surgery.

One of the most common congenital heart defects occurring in premature babies, PDA is a potentially life-threatening opening between two blood vessels leading from the heart. This channel, which is present in normally developing fetuses, is important prior to birth to allow oxygen-rich blood from the mother to circulate throughout the fetus’ body. For most infants, the pathway, or duct, seals itself shortly after birth. In some cases, primarily in babies born prematurely, the PDA fails to spontaneously close, which can make it difficult for babies to breathe normally due to increased blood flow to the lungs. PDA accounts for up to 10 percent of all congenital heart disease.

RELATED: Surgeons Successfully Implant World’s First 3D-Printed Rib – and They Plan On Doing Even More in the Future

Approximately 60,000 premature babies in the U.S. are born each year with a very low birth weight5, and nearly 12,000 (one out of five) of these have a hemodynamically significant PDA – a PDA that is large and causes symptoms – which will require urgent treatment for the baby to survive.

“This approval is a potentially life-saving advance for the very smallest premature infants that will help us treat these delicate babies who might otherwise not be able to survive,” said Evan Zahn, director of the Congenital Heart Program at Cedars-Sinai’s Smidt Heart Institute, and principal investigator for the study that led to FDA approval.

The Amplatzer Piccolo Occluder is a self-expanding, wire mesh device that is inserted through a small incision in the leg…

Click here to read more

The post FDA Approves World’s First Device That Could Save Thousands of Preemies From Common Heart Condition appeared first on FeedBox.

Ссылка на первоисточник
наверх